Omicron variant | Page 2 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Sunday
July 20, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SUNDAY, JULY 20, 2025

Omicron variant

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Omicron is a wake-up call for Covid-19 vaccine developers

Omicron is a wake-up call for Covid-19 vaccine developers
Coronavirus chronicle

Omicron is a wake-up call for Covid-19 vaccine developers

Dr Bijon Kumar Shil. Illustration: TBS
Covid-19 in Bangladesh

Soaring cases can make Omicron disastrous: Bijon K Shil

DGHS. Photo: Zia Chowdhury/TBS
Covid-19 in Bangladesh

Omicron knocking at the door: Health directorate

The active cases in India have further declined to 111,481, and have been the lowest in 537 days, according to the Union health ministry.(Reuters file photo)
Coronavirus chronicle

Fourth case of Omicron Covid-19 variant detected in India

A vial and a syringe are seen in front of a displayed EU flag and words "Omicron SARS-CoV-2" in this illustration taken, Nov 27, 2021. REUTERS/Dado Ruvic
Coronavirus chronicle

Omicron variant: At least 375 cases detected in 30 countries

Photo :Collected
Coronavirus chronicle

Omicron could be dominant in France within weeks, adviser says

DGHS. Photo: Zia Chowdhury/TBS
Covid-19 in Bangladesh

Authorities facing difficulty in tracing down South Africa returnees: DGHS

Photo: Health and Family Welfare Minister Zahid Maleque/ Collected
Covid-19 in Bangladesh

Health minister requests expats not to return home right now

Computer image of a betacoronavirus which is the type of virus linked to Covid-19
Covid-19 in Bangladesh

Omicron: Govt responses unclear, yet implementation the key

Omicron: Authorities red flag houses of 7 South Africa returnees in Brahmanbaria
Covid-19 in Bangladesh

Omicron: Authorities red flag houses of 7 South Africa returnees in Brahmanbaria

It is paramount, again, to follow all Covid-19 health guidelines, including wearing a mask. Photo: Saikat Bhadra/TBS
Panorama

Precautions and measures: What we should do to keep Omicron variant at bay 

Illustration: Collected
Covid-19 in Bangladesh

Bangladesh mulls mandatory no-Covid certificate for inbound passengers

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net